Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 23:2025:5555842.
doi: 10.1155/jdr/5555842. eCollection 2025.

Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia

Affiliations

Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia

Edomias Adyamseged Berhe et al. J Diabetes Res. .

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is an emerging global health concern that commonly occurs in patients with Type 2 diabetes mellitus (T2DM). However, there is limited literature on the epidemiology of NAFLD among adults with T2DM in Ethiopia. Therefore, this study is aimed at assessing the prevalence of NAFLD and its associated factors in patients with T2DM attending Yekatit 12 Hospital Medical College in Addis Ababa, Ethiopia. Methods: An institution-based, cross-sectional study was conducted. Data were collected using a pretested, structured data collection tool. All eligible consecutive patients diagnosed with T2DM were enrolled in this study. Data were entered into Microsoft Excel 2016 and analyzed using the Statistical Package for the Social Sciences (SPSS) Version 26. Descriptive statistics were used to summarize the data. Multivariable logistic regression was performed to identify associations between dependent and independent variables by calculating odds ratios with corresponding 95% confidence intervals. A p value of < 0.05 was considered statistically significant. Results: A total of 211 patients were enrolled in the study. Females (108; 51.2%) slightly predominated, and the mean (standard deviation) age of patients was 56.2 (11.0) years. Fatty liver was detected in 102 patients, representing a prevalence of 48.3% (95% CI: 42%-55%). Mild, moderate, and severe NAFLD accounted for 19.0%, 24.6%, and 4.7%, respectively. Female sex (AOR = 2.27 [95% CI: 1.17, 4.41]), obesity (AOR = 6.13 [95% CI: 2.15, 17.46]), borderline serum triglyceride levels (AOR = 3.22 [95% CI: 1.36, 7.58]), and high serum triglyceride levels (AOR = 2.29 [95% CI: 1.03, 5.10]) were significantly associated with the presence of NAFLD. Conclusions: NAFLD is highly prevalent among patients with T2DM in this Ethiopian cohort. Female sex, obesity, and elevated serum triglyceride levels are significant risk factors. These findings highlight the urgent need to address the silent epidemic of NAFLD among adults with T2DM in Ethiopia and emphasize the importance of educating patients on adopting healthy lifestyles to reduce the incidence of this condition.

Keywords: Ethiopia; Type 2 diabetes mellitus; magnitude; nonalcoholic fatty liver disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Magnitude of NAFLD among patients with Type 2 diabetes mellitus having regular follow-up at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia (n = 211).

Similar articles

References

    1. Abd El-Kader S. M., El-Den Ashmawy E. M. S. Non-Alcoholic Fatty Liver Disease: The Diagnosis and Management. World Journal of Hepatology . 2015;7(6):846–858. doi: 10.4254/wjh.v7.i6.846. - DOI - PMC - PubMed
    1. Puri P., Sanyal A. J. Nonalcoholic Fatty Liver Disease: Definitions, Risk Factors, and Workup. Clinics in Liver Disease . 2012;1(4):99–103. doi: 10.1002/cld.81. - DOI - PMC - PubMed
    1. Gluvic Z., Tomasevic R., Bojovic K., Obradovic M., Isenovic E. R. Non-Alcoholic Fatty Liver Disease: A Multidisciplinary Clinical Practice Approach—The Institutional Adaptation to Existing Clinical Practice Guidelines. Emergency and Critical Care Medicine . 2022;2(1):12–22. doi: 10.1097/EC9.0000000000000016. - DOI
    1. Benedict M., Zhang X. Non-Alcoholic Fatty Liver Disease: An Expanded Review. World Journal of Hepatology . 2017;9(16):715–732. doi: 10.4254/wjh.v9.i16.715. - DOI - PMC - PubMed
    1. Mantovani A., Scorletti E., Mosca A., Alisi A., Byrne C. D., Targher G. Complications, Morbidity and Mortality of Nonalcoholic Fatty Liver Disease. Metabolism . 2020;111 doi: 10.1016/j.metabol.2020.154170.154170 - DOI - PubMed

LinkOut - more resources